MOLECULIN BIOTECH INC (MBRX) Stock Income Statement
NASDAQ:MBRX - Nasdaq - US60855D3098 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 25.91M | 26.64M | 29.63M | 30.64M | 22.97M | |||
| Research and Development | 16.91M | 17.73M | 19.49M | 18.97M | 14.42M | |||
| Selling, General, and Administrative Expenses | 8.87M | 8.79M | 10.02M | 11.54M | 8.39M | |||
| Operating Income | -25.91M | -26.64M | -29.63M | -30.64M | -22.97M | |||
| Interest Income/Expense | 14.06M | 6.67M | 324.00K | 1.57M | 7.03M | |||
| Other Income/Expense | -8.60M | -804.00K | 48.00K | 40.00K | 40.00K | |||
| Non Recurring Items | N/A | -993.00K | -510.00K | N/A | N/A | |||
| Income Before Taxes | -23.23M | -21.76M | -29.77M | -29.02M | -15.89M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -23.23M | -21.76M | -29.77M | -29.02M | -15.89M | |||
| EBITDA | -25.78M | -26.52M | -29.50M | -30.51M | -22.80M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.61 | -6.32 | -15.07 | -15.22 | -8.87 | |||
| Non GAAP EPS | -5.61 | -6.94 | -15.07 | -15.15 | -8.85 | |||
| Statistics | ||||||||
All data in USD